Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Works by Viglietti, Giulia
Results: 7
1
2
Pharmacotherapy to protect ovarian function and fertility during cancer treatment.
- Published in:
- 2017
- By:
- Publication type:
- Editorial
3
Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?
- Published in:
- Clinical Medicine Insights: Reproductive Health, 2019, v. 13, p. 1, doi. 10.1177/1179558119828393
- By:
- Publication type:
- Article
4
Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?
- Published in:
- Clinical Medicine Insights: Reproductive Health, 2019, v. 13, n. 2, p. N.PAG, doi. 10.1177/1179558119828393
- By:
- Publication type:
- Article
5
Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?
- Published in:
- Clinical Medicine Insights: Reproductive Health, 2019, v. 13, p. N.PAG, doi. 10.1177/1179558119828393
- By:
- Publication type:
- Article
6
VIABLE OPTIONS FOR FERTILITY PRESERVATION IN BREAST CANCER PATIENTS: A FOCUS ON LATIN AMERICA.
- Published in:
- Clinical & Translational Investigation / Revista de Investigación Clínica, 2017, v. 69, n. 2, p. 103, doi. 10.24875/ric.17002179
- By:
- Publication type:
- Article
7
Potential Benefit of Intra-operative Administration of Ketorolac on Breast Cancer Recurrence According to the Patient's Body Mass Index.
- Published in:
- 2018
- By:
- Publication type:
- journal article